Femoral Versus Radial Invasive Arterial Pressure Monitoring in Cardiac Surgery Patients
Launched by GUILLAUME BESCH · Apr 28, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the best way to monitor blood pressure during and after heart surgery. Doctors often use two different arteries for this: the radial artery in the wrist and the femoral artery in the groin. The goal of this study is to find out if using the femoral artery provides more accurate blood pressure readings than the radial artery, which could help reduce the need for medication called norepinephrine that is used to raise blood pressure. Accurate blood pressure monitoring is crucial for patients undergoing major surgeries, as it can help prevent complications after surgery.
To participate in this study, patients must be adults aged 18 to 80 who are scheduled for elective heart surgery. They will be randomly assigned to either the radial or femoral artery monitoring group. Throughout the study, participants will have their blood pressure monitored continuously, and doctors will track any complications or health issues that arise in the first week after surgery. This research could provide important information on how to improve patient care during heart surgery, potentially leading to better outcomes and fewer complications.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female patients aged between 18 and 80 years inclusive
- • Scheduled cardiac surgery (time between anesthesia consultation and surgery \> 48 hours)
- • Affiliation with or beneficiary of the French national health insurance system
- • Signed informed consent indicating that the participant has understood the purpose and procedures of the study and agrees to participate and comply with its requirements and restrictions
- Exclusion Criteria:
- • Emergency surgery (time between surgical indication and surgery \< 24 hours)
- • Surgery requiring the use of two arterial pressure monitoring sites: e.g., aortic arch surgery, aortic dissection, etc.
- • Heart transplantation surgery
- • Mechanical circulatory support
- • Contraindication to radial artery catheterization: absence of collateral flow on Allen's test, Raynaud's syndrome, Buerger's disease, major hyperlipidemia
- • Contraindication to femoral artery catheterization: puncture of vascular prosthetic material in the femoral area (e.g., femoral bypass, femoral stenting, femoral trifurcation endarterectomy, femoral angioplasty)
- • Pregnant or breastfeeding women
- • Persons deprived of liberty by judicial or administrative decision; persons under compulsory psychiatric care; persons admitted to a healthcare or social institution for reasons other than research
- • Adults under legal protection measures (guardianship, trusteeship, or legal safeguard) or unable to give informed consent
- • Subjects currently under exclusion period of another clinical trial or listed in the national registry of research volunteers
About Guillaume Besch
Guillaume Besch is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a commitment to ethical practices and regulatory compliance, the organization specializes in the design and management of clinical trials across various therapeutic areas. By fostering collaboration with healthcare professionals, researchers, and regulatory bodies, Guillaume Besch aims to accelerate the development of safe and effective treatments, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Besançon, , France
Dijon, , France
Patients applied
Trial Officials
Guillaume Besch, M.D., Ph.D.
Principal Investigator
Centre Hospitalier Universitaire de Besançon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported